Bravo for this detailed analysis Pfeifer1982.
Given a favourable analysis based on available data, alongside your demonstrated interest and knowledge of stem cells, may I ask if you now added MSB to your portfolio?
Do you think MSB aGVHD FDA approval bodes well for Cynata in the short term given the completion in the GVHD segment and it being Cynata lead indication? Namely, would the positive macro signal overcome the negative competitive consideration.
Appreciate your opinion.
VFM
- Forums
- ASX - By Stock
- CYP
- Ann: Investor Presentation
Ann: Investor Presentation, page-534
-
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.0¢ |
Change
-0.040(14.3%) |
Mkt cap ! $43.11M |
Open | High | Low | Value | Volume |
28.0¢ | 28.0¢ | 24.0¢ | $136.0K | 544.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 24.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 446 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.245 |
1 | 23842 | 0.240 |
3 | 100000 | 0.235 |
2 | 12173 | 0.230 |
1 | 3334 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 446 | 1 |
0.255 | 5000 | 1 |
0.260 | 205000 | 2 |
0.265 | 10000 | 1 |
0.270 | 10000 | 1 |
Last trade - 15.59pm 20/06/2024 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online